Hi Paul!
If you look at the algorithm for MDS treatment you will see that a low risk patient with low HGB as the major problem often are treated with EPO drugs like Aranesp + eventually drugs like Neupogen if their own EPO initially is less than 500.
http://www.bloodjournal.org/content/124/18/2793
If that treatment fails they can try Vidaza.
Then we don't know if you have "no good" chromosome aberrations like problems with chromosome 7 or somatic mutations like TP53. If so it is important with a SCT even if you have low risk MDS.
Kind regards
Birgitta-A